These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 8004133)

  • 1. Morbidity and mortality of dialysis.
    NIH Consens Statement; 1993 Nov 1-3; 11(2):1-33. PubMed ID: 8004133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [When to start dialysis. The predialysis patient].
    Triolo G; Savoldi S
    G Ital Nefrol; 2008; 25 Suppl 41():S9-12, discussion S13-20. PubMed ID: 18473314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Peritoneal dialysis in the aged].
    Stojimirović B; Nesić V; Dimitrijević Z; Jovanović N
    Med Pregl; 1999; 52(9-10):369-74. PubMed ID: 10624386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adequacy in dialysis: intermittent versus continuous therapies.
    Misra M; Nolph KD
    Nefrologia; 2000; 20 Suppl 3():25-32. PubMed ID: 10835874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional status as a predictor of morbidity and mortality in maintenance dialysis patients.
    Kopple JD
    ASAIO J; 1997; 43(3):246-50. PubMed ID: 9152503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incident patient cohort study design with uncontrolled dose. Substantial over-estimation of mortality as a function of peritoneal dialysis dose?
    Gotch FA; Gentile DE; Keen ML; Amerling R; Folkert VW; Kliger AS; Shapiro WB
    ASAIO J; 1996; 42(5):M514-7. PubMed ID: 8944932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for improving long-term survival in peritoneal dialysis patients.
    Kendrick J; Teitelbaum I
    Clin J Am Soc Nephrol; 2010 Jun; 5(6):1123-31. PubMed ID: 20430945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of early or late referral to nephrologist over morbidity and mortality in hemodialysis].
    Gallego E; López A; Lorenzo I; López E; Llamas F; Illescas ML; Andrés E; Serrano A; Olivas E; Gómez Roldán C
    Nefrologia; 2003; 23(3):234-42. PubMed ID: 12891938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of peritoneal dialysis at Rijeka Clinical Hospital Center].
    Zivcić-Cosić S; Vlahović A; Grzetić M; Matić-Glazar D
    Acta Med Croatica; 2004; 58(3):215-20. PubMed ID: 15503685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival comparison between hemodialysis and peritoneal dialysis based on matched doses of delivered therapy.
    Keshaviah P; Collins AJ; Ma JZ; Churchill DN; Thorpe KE
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S48-52. PubMed ID: 11792762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Bradbury BD; Fissell RB; Albert JM; Anthony MS; Critchlow CW; Pisoni RL; Port FK; Gillespie BW
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):89-99. PubMed ID: 17699392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardioprotection: an essential component for predialysis chronic renal failure treatment].
    Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G
    Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
    Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
    Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictors of early death during dialysis].
    Caravaca F; Arrobas M; Pizarro JL; Cancho B; Cubero JJ; Espárrago JF; García MC; Sánchez-Casado E
    Nefrologia; 2001; 21(3):274-82. PubMed ID: 11471308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J; López-Gómez JM; Aljama P
    Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidisciplinary chronic kidney disease management improves survival on dialysis.
    Ravani P; Marinangeli G; Tancredi M; Malberti F
    J Nephrol; 2003; 16(6):870-7. PubMed ID: 14736015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
    Sahin S; Sahin GM; Ergin H; Kantarci G
    Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis.
    Collins AJ; Foley RN; Gilbertson DT; Chen SC
    Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S5-11. PubMed ID: 19996006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.